SeaChange Releases SEAware, Software for Predictive Matching of Drugs With Disease and Toxicity Targets
Published: Sep 11, 2013
SAN FRANCISCO--(BUSINESS WIRE)--SeaChange Pharmaceuticals Inc., a privately held platform and products pharmaceuticals company, is pleased to announce the immediate availability of SEAware™, its proprietary Similarity Ensemble Approach (SEA) software, that allows analysis and visualization tools for prediction of drug and other small molecule activity and toxicity against biological targets. Three levels of software are available directly from the SeaChange website.
Help employers find you! Check out all the jobs and post your resume.